235 related articles for article (PubMed ID: 26627824)
1. Hajdu Cheney Mouse Mutants Exhibit Osteopenia, Increased Osteoclastogenesis, and Bone Resorption.
Canalis E; Schilling L; Yee SP; Lee SK; Zanotti S
J Biol Chem; 2016 Jan; 291(4):1538-1551. PubMed ID: 26627824
[TBL] [Abstract][Full Text] [Related]
2. Antisense oligonucleotides targeting
Canalis E; Grossman TR; Carrer M; Schilling L; Yu J
J Biol Chem; 2020 Mar; 295(12):3952-3964. PubMed ID: 31992595
[TBL] [Abstract][Full Text] [Related]
3. An Antibody to Notch2 Reverses the Osteopenic Phenotype of Hajdu-Cheney Mutant Male Mice.
Canalis E; Sanjay A; Yu J; Zanotti S
Endocrinology; 2017 Apr; 158(4):730-742. PubMed ID: 28323963
[TBL] [Abstract][Full Text] [Related]
4. Sustained Notch2 signaling in osteoblasts, but not in osteoclasts, is linked to osteopenia in a mouse model of Hajdu-Cheney syndrome.
Zanotti S; Yu J; Sanjay A; Schilling L; Schoenherr C; Economides AN; Canalis E
J Biol Chem; 2017 Jul; 292(29):12232-12244. PubMed ID: 28592489
[TBL] [Abstract][Full Text] [Related]
5. High Bone Turnover in Mice Carrying a Pathogenic Notch2 Mutation Causing Hajdu-Cheney Syndrome.
Vollersen N; Hermans-Borgmeyer I; Cornils K; Fehse B; Rolvien T; Triviai I; Jeschke A; Oheim R; Amling M; Schinke T; Yorgan TA
J Bone Miner Res; 2018 Jan; 33(1):70-83. PubMed ID: 28856714
[TBL] [Abstract][Full Text] [Related]
6. Hairy and enhancer of split 1 is a primary effector of NOTCH2 signaling and induces osteoclast differentiation and function.
Yu J; Schilling L; Eller T; Canalis E
J Biol Chem; 2021 Dec; 297(6):101376. PubMed ID: 34742737
[TBL] [Abstract][Full Text] [Related]
7. The Hajdu Cheney mutation sensitizes mice to the osteolytic actions of tumor necrosis factor α.
Yu J; Canalis E
J Biol Chem; 2019 Sep; 294(39):14203-14214. PubMed ID: 31371452
[TBL] [Abstract][Full Text] [Related]
8. Hajdu-Cheney Syndrome, a Disease Associated with NOTCH2 Mutations.
Canalis E; Zanotti S
Curr Osteoporos Rep; 2016 Aug; 14(4):126-31. PubMed ID: 27241678
[TBL] [Abstract][Full Text] [Related]
9. Fracture healing in a mouse model of Hajdu-Cheney-Syndrome with high turnover osteopenia results in decreased biomechanical stability.
Ballhause TM; Jiang S; Xie W; Sevecke J; Dowling C; Dust T; Brandt S; Mertens PR; Yorgan TA; Schinke T; Frosch KH; Baranowsky A; Keller J
Sci Rep; 2023 Jul; 13(1):11418. PubMed ID: 37452111
[TBL] [Abstract][Full Text] [Related]
10. NOTCH2 Hajdu-Cheney Mutations Escape SCF
Fukushima H; Shimizu K; Watahiki A; Hoshikawa S; Kosho T; Oba D; Sakano S; Arakaki M; Yamada A; Nagashima K; Okabe K; Fukumoto S; Jimi E; Bigas A; Nakayama KI; Nakayama K; Aoki Y; Wei W; Inuzuka H
Mol Cell; 2017 Nov; 68(4):645-658.e5. PubMed ID: 29149593
[TBL] [Abstract][Full Text] [Related]
11. Clinical and experimental aspects of notch receptor signaling: Hajdu-Cheney syndrome and related disorders.
Canalis E
Metabolism; 2018 Mar; 80():48-56. PubMed ID: 28941602
[TBL] [Abstract][Full Text] [Related]
12. Mice harboring a Hajdu Cheney Syndrome mutation are sensitized to osteoarthritis.
Zanotti S; Yu J; Bridgewater D; Wolf JM; Canalis E
Bone; 2018 Sep; 114():198-205. PubMed ID: 29940267
[TBL] [Abstract][Full Text] [Related]
13. Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab.
Adami G; Rossini M; Gatti D; Orsolini G; Idolazzi L; Viapiana O; Scarpa A; Canalis E
Bone; 2016 Nov; 92():150-156. PubMed ID: 27592446
[TBL] [Abstract][Full Text] [Related]
14. Bone Structural Characteristics and Response to Bisphosphonate Treatment in Children With Hajdu-Cheney Syndrome.
Sakka S; Gafni RI; Davies JH; Clarke B; Tebben P; Samuels M; Saraff V; Klaushofer K; Fratzl-Zelman N; Roschger P; Rauch F; Högler W
J Clin Endocrinol Metab; 2017 Nov; 102(11):4163-4172. PubMed ID: 28938420
[TBL] [Abstract][Full Text] [Related]
15. NOTCH2 promotes osteoclast maturation and metabolism and modulates the transcriptome profile during osteoclastogenesis.
Canalis E; Schilling L; Yu J; Denker E
J Biol Chem; 2024 Feb; 300(2):105613. PubMed ID: 38159855
[TBL] [Abstract][Full Text] [Related]
16. Hajdu-Cheney syndrome: a review.
Canalis E; Zanotti S
Orphanet J Rare Dis; 2014 Dec; 9():200. PubMed ID: 25491639
[TBL] [Abstract][Full Text] [Related]
17. Mutations in NOTCH2 cause Hajdu-Cheney syndrome, a disorder of severe and progressive bone loss.
Simpson MA; Irving MD; Asilmaz E; Gray MJ; Dafou D; Elmslie FV; Mansour S; Holder SE; Brain CE; Burton BK; Kim KH; Pauli RM; Aftimos S; Stewart H; Kim CA; Holder-Espinasse M; Robertson SP; Drake WM; Trembath RC
Nat Genet; 2011 Mar; 43(4):303-5. PubMed ID: 21378985
[TBL] [Abstract][Full Text] [Related]
18. Osteoblast-specific Notch2 inactivation causes increased trabecular bone mass at specific sites of the appendicular skeleton.
Yorgan T; Vollersen N; Riedel C; Jeschke A; Peters S; Busse B; Amling M; Schinke T
Bone; 2016 Jun; 87():136-46. PubMed ID: 27102824
[TBL] [Abstract][Full Text] [Related]
19. Notch signaling suppresses glucose metabolism in mesenchymal progenitors to restrict osteoblast differentiation.
Lee SY; Long F
J Clin Invest; 2018 Dec; 128(12):5573-5586. PubMed ID: 30284985
[TBL] [Abstract][Full Text] [Related]
20. Induction of the Hajdu-Cheney Syndrome Mutation in CD19 B Cells in Mice Alters B-Cell Allocation but Not Skeletal Homeostasis.
Yu J; Zanotti S; Schilling L; Schoenherr C; Economides AN; Sanjay A; Canalis E
Am J Pathol; 2018 Jun; 188(6):1430-1446. PubMed ID: 29545197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]